ARCHIVES

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 37 No. 36 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

November 1, 1985

NCI Continues Making Improvements In Contract Management

May 22, 1981

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980